| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| spironolactone | Tablet, uncoated | 25 mg | Resolved | Available | Manufacturing | 2/06/2025 |
| Semaglutide | Injection, solution | 1.34 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 1/06/2025 |
| hydralazine hydrochloride | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 1/06/2025 |
| Semaglutide | Injection, solution | .68 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 1/06/2025 |
| fampridine | Tablet, modified release | 10 mg | Anticipated | Available | Manufacturing | 31/05/2025 |
| gabapentin | Capsule, hard | 300 mg | Resolved | Available | Manufacturing | 30/05/2025 |
| prazosin hydrochloride | Tablet, uncoated | 2.19 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 30/05/2025 |
| ciclesonide | Spray, nasal | 50 microgram/actuation | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 30/05/2025 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 30/05/2025 |
| sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Current | Limited Availability | Manufacturing | 30/05/2025 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 30/05/2025 |
| celecoxib | Capsule, hard | 200 mg | Current | Unavailable | Manufacturing | 30/05/2025 |
| bendamustine hydrochloride | Injection, powder for | 100 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 30/05/2025 |
| bendamustine hydrochloride | Injection, powder for | 25 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 30/05/2025 |
| linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 30/05/2025 |
| telmisartan~hydrochlorothiazide | Tablet, multilayer | 80 mg~12.5 mg | Resolved | Available | Manufacturing | 30/05/2025 |
| calcipotriol~betamethasone dipropionate | Ointment | 52.2 microgram/g~643 microgram/g | Current | Unavailable | Manufacturing | 30/05/2025 |
| imatinib mesilate | Tablet, film coated | 119.5 mg | Resolved | Available | Unexpected increase in consumer demand | 30/05/2025 |
| midodrine hydrochloride | Tablet | 5 mg | Anticipated | Available | Manufacturing | 30/05/2025 |
| adrenaline (epinephrine) | Injection, solution | 500 microgram | Anticipated | Available | Manufacturing | 30/05/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 30/05/2025 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 56.69 mg | Current | Unavailable | Manufacturing | 30/05/2025 |
| rivaroxaban | Tablet, film coated | 2.5 mg | Current | Unavailable | Unexpected increase in consumer demand | 30/05/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 30/05/2025 |
| spironolactone | Tablet, film coated | 25 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 30/05/2025 |
| midazolam | Injection, solution | 5 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 30/05/2025 |
| Tiger snake antivenom | Injection, concentrated | 3000 U | Current | Limited Availability | Manufacturing | 30/05/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Anticipated | Available | Manufacturing | 30/05/2025 |
| indapamide hemihydrate | Tablet, modified release | 1.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 29/05/2025 |
| amiodarone hydrochloride | Injection, solution | 150 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 29/05/2025 |
| bicalutamide | Tablet, film coated | 50 mg | Anticipated | Available | Unexpected increase in consumer demand | 29/05/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Anticipated | Available | Manufacturing | 29/05/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~10 mg | Current | Limited Availability | Manufacturing | 29/05/2025 |
| simvastatin~ezetimibe | Tablet | 20 mg~10 mg | Current | Limited Availability | Manufacturing | 29/05/2025 |
| carboplatin | Injection, solution | 450 mg | Current | Limited Availability | Manufacturing | 29/05/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 29/05/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 10.341 mg~10 mg | Current | Unavailable | Manufacturing | 29/05/2025 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Current | Limited Availability | Manufacturing | 29/05/2025 |
| flecainide acetate | Tablet | 50 mg | Anticipated | Available | Manufacturing | 29/05/2025 |
| cabergoline | Tablet, uncoated | 1 mg | Anticipated | Available | Manufacturing | 29/05/2025 |
| quinapril hydrochloride~hydrochlorothiazide | Tablet, film coated | 10.832 mg~12.5 mg | Current | Unavailable | Manufacturing | 29/05/2025 |
| hydrochlorothiazide~quinapril hydrochloride | Tablet, film coated | 12.5 mg~21.664 mg | Current | Unavailable | Manufacturing | 29/05/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 28/05/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| midazolam | Injection, solution | 5 mg/mL | Resolved | Available | Manufacturing | 28/05/2025 |
| pentetic acid | Injection, powder for | 5 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| medronic acid | Injection, powder for | 10 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| sodium fluoride | Injection, concentrated | 1 mg/mL | Current | Unavailable | Manufacturing | 28/05/2025 |
| olanzapine | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| olanzapine | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| perindopril erbumine | Tablet | 8 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| perindopril arginine | Tablet, film coated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 28/05/2025 |
| perindopril arginine | Tablet, film coated | 5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 28/05/2025 |
| perindopril arginine | Tablet, film coated | 2.5 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 28/05/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| Vespula spp venom | Injection, powder for | 550 microgram | Resolved | Available | Manufacturing | 28/05/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| bicalutamide | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.05 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Current | Unavailable | Unexpected increase in consumer demand | 28/05/2025 |
| midazolam | Injection, solution | 15 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| oxytocin | Injection, solution | 5 IU/mL | Current | Limited Availability | Unexpected increase in consumer demand | 28/05/2025 |
| fluticasone propionate~salmeterol xinafoate | Inhalation, powder for | 250 microgram/actuation~72.5 microgram/actuation | Resolved | Available | Manufacturing | 28/05/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 28/05/2025 |
| epirubicin hydrochloride | Injection, concentrated | 200 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| clonidine hydrochloride | Tablet | 100 microgram | Current | Unavailable | Unexpected increase in consumer demand | 28/05/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 28/05/2025 |
| timolol maleate | Eye Drops, solution | 6.83 mg/mL | Resolved | Available | Commercial Changes / Commercial viability | 28/05/2025 |
| levothyroxine sodium | Tablet | .1 mg | Resolved | Available | Manufacturing | 28/05/2025 |
| Fremanezumab | Injection, solution | 225 mg | Resolved | Available | Unexpected increase in consumer demand | 28/05/2025 |
| chloramphenicol | Eye Drops, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 28/05/2025 |
| pirfenidone | Tablet, film coated | 267 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 28/05/2025 |
| pirfenidone | Tablet, film coated | 801 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 28/05/2025 |
| paracetamol | Tablet, modified release | 665 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 28/05/2025 |
| melatonin | Capsule, hard | 2 mg | Anticipated | Available | Unexpected increase in consumer demand | 28/05/2025 |
| sodium nitroprusside | Injection, concentrated | 50 mg | Current | Unavailable | Commercial Changes / Commercial viability | 28/05/2025 |
| amidotrizoate meglumine~sodium amidotrizoate | Injection, solution | 260 mg/mL~40 mg/mL | Current | Unavailable | Manufacturing | 28/05/2025 |
| framycetin sulfate~gramicidin~dexamethasone | Ear Drops | 5 mg/mL~.05 mg/mL~.5 mg/mL | Current | Limited Availability | Manufacturing | 28/05/2025 |
| doxorubicin hydrochloride | Injection, concentrated | 20 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| gemfibrozil | Tablet, film coated | 600 mg | Resolved | Available | Manufacturing | 28/05/2025 |
| olanzapine | Injection, powder for | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 28/05/2025 |
| amoxicillin sodium | Injection, powder for | 1060 mg | Current | Limited Availability | Manufacturing | 28/05/2025 |
| levetiracetam | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 27/05/2025 |
| risedronate sodium hemipentahydrate | Tablet, film coated | 173.4 mg | Anticipated | Available | Manufacturing | 27/05/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 27/05/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Anticipated | Available | Manufacturing | 27/05/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 27/05/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 27/05/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~43.376 mg | Current | Limited Availability | Manufacturing | 27/05/2025 |
| dutasteride | Capsule, soft | 500 microgram | Resolved | Available | Manufacturing | 27/05/2025 |
| Liraglutide | Injection, solution | 6 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 27/05/2025 |
| cisatracurium besilate | Injection, solution | 14.07 mg | Resolved | Available | Manufacturing | 27/05/2025 |
| sodium iodide(131I) | Oral Liquid, solution | 50 MBq | Current | Limited Availability | Manufacturing | 27/05/2025 |
| sodium iodide(131I) | Capsule, hard | 50 MBq | Current | Unavailable | Manufacturing | 27/05/2025 |
| fenofibrate | Tablet | 145 mg | Current | Unavailable | Manufacturing | 27/05/2025 |
| lacosamide | Tablet, film coated | 200 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 27/05/2025 |
| deferasirox | Tablet, film coated | 90 mg | Current | Limited Availability | Manufacturing | 27/05/2025 |
| timolol maleate~dorzolamide hydrochloride | Eye Drops, solution | 6.83 mg/mL~22.26 mg/mL | Current | Limited Availability | Manufacturing | 27/05/2025 |
| methylphenidate hydrochloride | Capsule, hard | 10 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 27/05/2025 |
| lanreotide acetate | Injection, solution | 66.67 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 27/05/2025 |
| sodium iodide(131I) | Oral Liquid, solution | 1201 MBq | Current | Limited Availability | Manufacturing | 27/05/2025 |
| sodium pertechnetate(99mTc) | Injection, solution | 20 GBq | Current | Limited Availability | Manufacturing | 27/05/2025 |
| sodium pertechnetate(99mTc) | Injection | 370 GBq | Current | Limited Availability | Manufacturing | 27/05/2025 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 27/05/2025 |
| ramipril | Capsule, hard | 5 mg | Current | Unavailable | Manufacturing | 26/05/2025 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Resolved | Available | Manufacturing | 26/05/2025 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/05/2025 |
| tranexamic acid | Injection, solution | 1000 mg | Current | Unavailable | Commercial Changes / Commercial viability | 26/05/2025 |
| lacosamide | Tablet, film coated | 100 mg | Resolved | Available | Unexpected increase in consumer demand | 26/05/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 26/05/2025 |
| buprenorphine hydrochloride | Tablet, uncoated | .216 mg | Anticipated | Available | Manufacturing | 26/05/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Manufacturing | 26/05/2025 |
| topotecan hydrochloride | Injection, powder for | 4 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 26/05/2025 |
| estradiol~dydrogesterone | Tablet, film coated | 2 mg~10 mg | Resolved | Available | Manufacturing | 26/05/2025 |
2025年6月2日